← Back to Search

On-demand transportation for Sudden Infant Death Syndrome

N/A
Waitlist Available
Led By Erinn M Hade, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to consent to communication by phone, text, and email
Access to a telephone (mobile or landline), tablet or computer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year post delivery
Awards & highlights

Study Summary

This study is evaluating whether a new way of delivering transportation services to pregnant women can improve outcomes for their children.

Eligible Conditions
  • Sudden Infant Death Syndrome
  • Preterm Birth

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year post delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year post delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Satisfaction with transportation services: scale
Secondary outcome measures
Kotelchuck Adequacy of Prenatal Care Utilization index
The proportion of deliveries < 37 weeks gestation
The proportion of infants who die within one year of birth

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: On-demand transportationExperimental Treatment1 Intervention
Women randomized to the intervention group will be able to contact the transportation broker via telephone, web portal, or the broker's mobile application. In addition to the current trips provided by their Medicaid managed care organization , women assigned to the intervention group will be provided with extra trips to the pharmacy and grocery store or food bank.
Group II: Usual transportationActive Control1 Intervention
Women assigned to the usual care group will receive the usual transportation services from their Medicaid managed care organization.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
821 Previous Clinical Trials
500,980 Total Patients Enrolled
Erinn M Hade, PhDPrincipal InvestigatorOhio State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~25 spots leftby Mar 2025